Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

81. Breast cancer mortality in organised mammography screening in Denmark: comparative study. Full Text available with Trip Pro

Breast cancer mortality in organised mammography screening in Denmark: comparative study. To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up.We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast cancer mortality in areas (...) where screening was used with the change in areas where it was not used during 10 years before screening was introduced and for 10 years after screening was in practice (starting five years after introduction of screening).Copenhagen, where mammography screening started in 1991, and Funen county, where screening was introduced in 1993. The rest of Denmark (about 80% of the population) served as an unscreened control group.All Danish women recorded in the Cause of Death Register and Statistics

2010 BMJ

82. Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women

Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women | Evidence-Based Nursing We use cookies to improve our service and to tailor (...) name or password? You are here A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Article Text Therapeutics Randomised controlled trial A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Maggi Banning Statistics

2010 Evidence-Based Nursing

83. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis

Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

84. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Full Text available with Trip Pro

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of screening for breast cancer, using magnetic resonance imaging (MRI), screen-film mammography, or both, for women with mutations of the breast cancer gene BRCA1. The authors concluded that annual mammography and MRI detected

2010 NHS Economic Evaluation Database.

85. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF.

Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. – Clinical Correlations Search Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. November 17, 2009 2 min read Aalok Turakhia, MD As the debate over when to begin screening mammography in women rages on, the United States Prevention Service Task Force (USPSTF) added fuel to the fire by releasing a new recommendation statement (...) in the November 17th issue of the Annals of Internal Medicine. Applying to women aged ≥40 who are not at an increased genetic risk or have had chest irradiation, the USPSTF now recommends biennial screening in women between ages 50-74. In February 2002, the task force first recommended that annual or biennial screening start at age 40; however, in a revised statement, “The USPSTF recommends against routine screening mammography in women aged 40 to 49 years.” It adds, “The decision to start regular, biennial

2009 Clinical Correlations

86. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. Full Text available with Trip Pro

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. Despite trials of mammography and widespread use, optimal screening policy is controversial.To evaluate U.S. breast cancer screening strategies.6 models using common data elements.National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects.A contemporary population cohort.Lifetime.Societal.20 screening strategies with varying

2009 Annals of Internal Medicine

87. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis

Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

88. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

89. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Full Text available with Trip Pro

Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Ahern CH, Shen Y Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to assess the cost-effectiveness of breast cancer screening strategies that combined mammography and clinical breast examination. The authors suggested that, due to its superior cost-effectiveness, the strategy of mammography and clinical breast examination every two years, and given

2009 NHS Economic Evaluation Database.

90. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

2009 Health Technology Assessment (HTA) Database.

91. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) that for organised screening. There were a few limitations to the study, but the methods and results were presented well, and the authors’ conclusions appear to be appropriate. Type of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective The objective was to compare the cost-effectiveness of alternative screening programmes for breast cancer in women aged 50 to 69 years in Switzerland. Interventions Organised biennial mammography screening was compared with opportunistic

2009 NHS Economic Evaluation Database.

92. Premedication to Reduce Discomfort during Screening Mammography Full Text available with Trip Pro

Premedication to Reduce Discomfort during Screening Mammography To test the hypothesis that premedication with acetaminophen, ibuprofen, and/or 4% lidocaine gel would decrease discomfort and improve satisfaction with screening mammography in women who expect a higher level of discomfort.In this HIPAA-compliant, institutional review board-approved, prospective, double-blinded, placebo-controlled clinical trial, 418 women aged 32-89 years who expected substantial discomfort with screening (...) mammography were randomly divided to receive premedication with acetaminophen, ibuprofen, and/or 4% lidocaine gel. Subjects provided informed written consent. The primary outcome was discomfort. Secondary outcomes were satisfaction and plans for future mammography on the basis of discomfort. Subjects completed structured questionnaires with visual analog scales to measure discomfort and satisfaction. A generalized linear mixed-models framework was used to assess the effect of medications on discomfort

2008 EvidenceUpdates Controlled trial quality: predicted high

93. Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries

Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Article Text Treatment Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright

2008 Evidence-Based Nursing

94. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy Full Text available with Trip Pro

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy The effect of combined hormone therapy on breast cancer detection is not established.We examined the effect of combined hormone therapy on breast cancer detection in the Women's Health Initiative trial, which randomized 16,608 postmenopausal women to receive conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d) or placebo. Mammography and breast examinations were (...) performed at baseline and annually per protocol, with breast biopsies based on clinical findings. The effects of conjugated equine estrogens plus medroxyprogesterone acetate on breast cancer detection was determined throughout 5.6 years of intervention using receiver operating characteristic analyses to evaluate mammography results.Conjugated equine estrogens plus medroxyprogesterone acetate increased the cumulative frequency of mammograms with abnormalities vs placebo (35.0% vs 23.0%; P < .001), which

2008 EvidenceUpdates Controlled trial quality: uncertain

95. (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007).

(1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient

2008 American Cancer Society

96. Effect of cost sharing on screening mammography in medicare health plans. (Abstract)

Effect of cost sharing on screening mammography in medicare health plans. Policies that increase patients' share of health care expenses decrease the use of discretionary health services but also may reduce the use of important preventive care such as mammography.We reviewed coverage for mammography within 174 Medicare managed-care plans from 2001 through 2004. Among 550,082 individual-level observations for 366,475 women between the ages of 65 and 69 years, we compared rates of biennial breast (...) -cancer screening in plans requiring cost sharing for mammography with screening rates in plans with full coverage. We also performed a longitudinal analysis of screening rates in plans that changed from full coverage to cost sharing for mammography as compared with rates in matched control plans that did not institute cost sharing.The number of plans with cost sharing for mammography, which we defined as requiring a copayment of more than $10 or coinsurance of more than 10% for screening mammography

2008 NEJM

97. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. Full Text available with Trip Pro

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. Screening ultrasound may depict small, node-negative breast cancers not seen on mammography.To compare the diagnostic yield, defined as the proportion of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer.From April 2004 to February (...) (assessed by the area under the receiver operating characteristic curve) of combined mammography plus ultrasound vs mammography alone and the positive predictive value of biopsy recommendations for mammography plus ultrasound vs mammography alone.Forty participants (41 breasts) were diagnosed with cancer: 8 suspicious on both ultrasound and mammography, 12 on ultrasound alone, 12 on mammography alone, and 8 participants (9 breasts) on neither. The diagnostic yield for mammography was 7.6 per 1000 women

2008 JAMA Controlled trial quality: predicted high

98. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach

MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

99. Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate

Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

100. Single reading with computer-aided detection for screening mammography. (Abstract)

Single reading with computer-aided detection for screening mammography. The sensitivity of screening mammography for the detection of small breast cancers is higher when the mammogram is read by two readers rather than by a single reader. We conducted a trial to determine whether the performance of a single reader using a computer-aided detection system would match the performance achieved by two readers.The trial was designed as an equivalence trial, with matched-pair comparisons between (...) the cancer-detection rates achieved by single reading with computer-aided detection and those achieved by double reading. We randomly assigned 31,057 women undergoing routine screening by film mammography at three centers in England to double reading, single reading with computer-aided detection, or both double reading and single reading with computer-aided detection, at a ratio of 1:1:28. The primary outcome measures were the proportion of cancers detected according to regimen and the recall rates

2008 NEJM Controlled trial quality: predicted high